On the road to 100% open access publications
Along with the SNSF, the NCCR Chemical Biology goes hand in hand with the national strategy to reach 100% open access publications by 2020. In 2018, we reached nearly 50% of open access publications.
Along with the SNSF, the NCCR Chemical Biology goes hand in hand with the national strategy to reach 100% open access publications by 2020. In 2018, we reached nearly 50% of open access publications.
Hot from the press of Nature Chemistry and Nature Cell Biology. Congrats to our NCCR groups – Matile, Roux and Loewith – , who made it together!
New publication in Cancer Cell: Protein mTOR stimulates the production of lipids in liver tumors.
Facing a camera, one young researcher presents his work and gives emphasis on the biochemical problem behind it.
Development of high-performance synthetic binding proteins, termed monobodies, that prove to be effectively and specifically targeted to the SH2 domains of SFKs.
Combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery, co-funded by the NCCR Chemical Biology, opens a new path for drug-drug synergy.
If you are interested in building up your own company and you have a great business idea that you would like to bring forward, you may want to sign up for this special workshop.
The NCCR Chemical Biology Annual Retreat 2016 took place last June and was held, just like the previous years, at the Eurotel Victoria, Villars-sur-Ollon, in Vaud.
This second issue is dedicated to entrepreneurship. We seeked the advice of professionnals and we focused on activities of our NCCR and other Swiss institutions that aim at lending a helping hand to aspiring entrepreneurs.
For its 10th anniversary, Nature Chemical Biology asked the question: “define chemical biology ?” to a panel of scientists.